ESR1 and uterine corpus sarcoma: Although the functional significance of ER expression in uterine sarcoma is unclear, previous immunohistochemical analyses indicate that it is expressed in 70–75% of L- and H-ESS, 50–60% of LMS, and 30–35% of CS specimens [6, 7].